High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

Những quyển sách tương tự

• Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
  Bằng: Somlo, G, et al.
  Được phát hành: (2002)
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
  Bằng: Burnell, Margot, et al.
  Được phát hành: (2010)
• Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer
  Bằng: VanderWalde, A., et al.
  Được phát hành: (2012)
• Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study
  Bằng: Vaz-Luis, Ines, et al.
  Được phát hành: (2020)
• High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer.
  Bằng: Ferguson, J. E., et al.
  Được phát hành: (1993)